Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

What is the Difference Between “Venting” and “Unloading”?

Navin Kapur, MD, succinctly explains the concept of ventricular unloading.

Study Finds pVADs are Cost-Effective for High-Risk PCI

In the era of increasing healthcare costs, the cost-effectiveness of traditional versus emerging technologies is an ongoing consideration when evaluating long-term outcomes.

Automated Impella Controller™ (AIC): Understanding and Navigating the Placement Screen

Jo Kajewski, global Impella® trainer, describes the soft buttons, waveforms, and other information displayed on the AIC placement screen when a patient is on Impella support. 

Assessing and Maintaining the Impella® Access Site

Jo Kajewski, advanced Impella trainer, discusses how to assess the Impella access site, change dressings, and help prevent access site bleeding to improve patient outcomes. 

FAQ: Is There Randomized Controlled Trial Data Available for Impella® Heart Pump Use in Cardiogenic Shock?

This FAQ discusses the challenges of obtaining RCT data for cardiogenic shock and presents the clinical data that is currently available and ongoing.

Managing Impella® Position Using Imaging and the Automated Impella Controller™

Jo Kajewski, advanced Impella trainer, discusses how Impella should appear on baseline echo and steps for repositioning Impella if a positioning alarm occur. 

Discover New Data on Protected PCI versus Bailout PCI

Alexander Truesdell, MD, discusses Protected PCI versus bailout PCI using data from the cVAD Study and the PROTECT III study. 

Techniques to Reduce Bleeding with Large Bore Access Devices

Amir Kaki, MD, discusses techniques and best practices for access and closure to reduce bleeding and complications with large-bore access devices.

Looking to Clinical Evidence in Cardiogenic Shock

William O’Neill, MD discusses cardiogenic shock treatment in light of the lack of randomized, controlled clinical trial data for cardiogenic shock.

Door-to-Unload (DTU) in STEMI Trial Summary: Pilot Trial and Pivotal Trial Design

Navin K. Kapur, MD, FACC, FSCAI, FAHA, discusses how acute cardiac unloading limits infarct scar formation in the context of the DTU-STEMI Pilot trial and Pivotal trial.

Assessing Impella® Heart Pump Position with Echocardiography

Echocardiography for assessing Impella position—a discussion with Clinical Support Specialist Michael Galvin, RDCS.

Right Heart Failure and the Impella RP® with SmartAssist® Heart Pump

This FAQ discusses the causes, incidence, and diagnosis of right heart failure and how the Impella RP with SmartAssist heart pump can support the right side of the heart.

What is the purpose of the STEMI DTU™ RCT?

This FAQ provides key information about the purpose and design of the STEMI DTU pivotal randomized controlled trial and how to participate.

FAQ: What Is the Clinical Evidence That Supports the Benefit of Placing the Impella® Heart Pump Pre-PCI?

A preponderance of evidence from the FDA cVAD Study, Impella Quality Database and the physician-initiated NSCI study supports the recommendation that placing Impella 2.5® or Impella CP® pre-PCI improves outcomes.

Data from the NCSI Study Demonstrates 72% Survival with 98% Native Heart Recovery

William O'Neill, MD, discusses data from the National Cardiogenic Shock Initiative (NCSI) study presented at the 2019 SCAI Scientific Sessions.

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].